Compare OGN & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | OPRA |
|---|---|---|
| Founded | 1923 | 1996 |
| Country | United States | Norway |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | 2018 |
| Metric | OGN | OPRA |
|---|---|---|
| Price | $9.69 | $17.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $11.75 | ★ $22.75 |
| AVG Volume (30 Days) | ★ 6.4M | 453.0K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | 0.86% | ★ 4.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.45 | $21.29 |
| Revenue Next Year | $1.67 | $15.34 |
| P/E Ratio | ★ $12.94 | $13.62 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $11.71 |
| 52 Week High | $13.25 | $21.06 |
| Indicator | OGN | OPRA |
|---|---|---|
| Relative Strength Index (RSI) | 76.35 | 71.06 |
| Support Level | $8.63 | $15.55 |
| Resistance Level | $10.10 | $17.72 |
| Average True Range (ATR) | 0.58 | 0.58 |
| MACD | 0.42 | 0.25 |
| Stochastic Oscillator | 96.66 | 90.53 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.